logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Silvia Antolín

Universidade da Coruña
H指数:26
被引数:2,884

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Information needs and barriers to patient-centered care in oncology: EtnobreastHER2; an ethnographic study with HER2+ MBC patients and their healthcare providers

肿瘤学中患者为中心的护理信息需求与障碍：EtnobreastHER2；一项针对HER2+ MBC患者及其医疗保健提供者的民族志研究

Frontiers in Medicine
IF3
2025-10-230
OAAI
José Ángel García-Sáenz; Álvaro Rodríguez-Lescure; Silvia Antolin; Blanca Cantos; Miguel Ángel Seguí; María Antonia Gimón; Raül Rubio Renau; Carlota Solà Marsiñach; Jesús Martín Illán; Rocío Fonseca Vallejo; Yaiza Gimeno Guadalupe; Noelia Alfaro Oliver; Joaquín Gavilá
Do patients with HER2+ MBC and their HCPs speak the same language? Perceptions and uses of chronic disease and metastatic treatment arising from the EtnobreastHER2 study

HER2+ MBC患者及其医疗保健专业人员（HCPs）是否使用相同的语言？源自EtnobreastHER2研究的对慢性疾病和转移性治疗的观点与用法

Patient Education and Counseling
IF3.1
2025-08-050
OA
Joaquín Gavilá; Álvaro Rodríguez-Lescure; Silvia Antolín; Blanca Cantos; Miguel Ángel Seguí; María Antonia Gimón; Raül Rubio Renau; Carlota Solà Marsiñach; Jesús Martín Illán; Rocío Fonseca Vallejo; Yaiza Gimeno Guadalupe; Noelia Alfaro Oliver; José Ángel García-Sáenz
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
BREAST CANCER RESEARCH AND TREATMENT
IF3
2025-03-010
PRE
Shinn, Eileen; Zahrieh, David; Demichele, Angela; Zdenkowski, Nick; Lemieux, Julie; Mao, Jun; Bjelic-Radisic, Vesna; Naughton, Michelle J.; Pfeiler, Georg; Gelmon, Karen; Balko, Justin M.; Egle, Daniel; Zoppoli, Gabriele; Traina, Tiffany; Jimenez, Miguel Martin; Novoa, Silvia Antolin; Haddad, Tufia; Chan, Arlene; Ring, Alistair; Wolff, Antonio; Symmans, William Fraser; Ponce Lorenzo, Jose; Sabanathan, Dhanusha; Burstein, Hal J.; Nowecki, Zbigniew Ireneusz; Pristauz-Telsnigg, Gunda; Brufsky, Adam; Bellet-Ezquerra, Meritxell; Foukakis, Theodoros; Novik, Yelena; Rubovszky, Gabor; Singer, Christian F.; Muehlbacher, Karoline; Filho, Otto Metzger; Goulioti, Theodora; Law, Ernest; Partridge, Ann H.; Carey, Lisa A.; Zoroufy, Alex; Hlauschek, Dominik; Fesl, Christian; Mayer, Erica L.; Gnant, Michael
Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays

GEICAM/2011-06试验中HER2-low乳腺癌的患病率：标准化免疫组化检测在HER2-low分类上的一致性

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Rojo, F.; Calvo-Martinez, L.; Bermejo, B.; Bernet, L.; Burgues, O.; Garcia-Caballero, T.; Lopez-Tarruella Cobo, S.; Perez, S.; Antolin-Novoa, S.; Cejalvo, J. M.; Jerez Gilarranz, Y.; Morales Estevez, C.; Reboredo Rendo, C.; Martinez, M. T. M.; Herranz, J.; Rincon Sanchez, R.; Caballero, R.; Barnadas, A.; De la Haba Rodriguez, J.; Martin Jimenez, M.
Key landmarks of male advanced breast cancer: Results of the GEICAM/2016-04 study

男性晚期乳腺癌的关键里程碑：GEICAM/2016-04研究的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Martinez, N.; Martinez del Prado, M. P.; Hernando Melia, C.; Recalde Penabad, S.; Munoz, A. S.; Morales Pancorbo, D.; Santisteban Eslava, M.; Fernandez Perez, I.; Del Barco Berron, S.; Zamora Adelantado, E.; Iranzo, V.; Martos Cardenas, T.; Martinez de Duenas, E.; Antolin-Novoa, S.; Guerrero Zotano, A. L.; Ferreira Alonso, R.; Esteban Esteban, C.; Enrech Frances, S.; Tejera Hernandez, A. A.; Urruticoechea, A.
Randomized Phase II trial evaluating three antidiarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gil-Gil, Miguel; Martin, Miguel; Carrasco, Eva; Galve, Elena; Martinez-Janez, Noelia; Gonzalez-Santiago, Santiago; Adamo, Barbara; Valero, Maria; Martinez, Clara; Guerrero, Angel; Novoa, Silvia Antolin; Ruiz-Borrego, Manuel; Blancas, Isabel; Andres, Raquel; Alonso-Romero, Jose L.; Andrea, Vethencourt; Chacon, J. Ignacio; Chavarria, Natalia; Espinosa, Enrique; Hernando, Blanca; Adrover, Encarnacion; Rojo, Federico; Casas, Maribel; McCulloch, Leanne; Vedovato, Jean-Claude
BRCA mutated Male Breast Cancer, hallmarks of a distinct disease. Data from the Spanish Male Breast Cancer Registry (GEICAM/2016-04)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Martinez-Janez, Noelia; Martinez, Purificacion; Hernando, Cristina; Recalde, Sabela; Sanchez, Alfonso; Morales, David; Santisteban, Marta; Fernandez, Isaura; Del Barco, Sonia; Zamora, Esther; Iranzo, Vega; Martos, Tamara; Martinez-de Duenas, Eduardo; Novoa, Silvia Antolin; Dominguez, Severina; Dominguez, Paula; Echarri, Ma Jose; Bertran, Ana Santaballa; Mira, Xavier; Blasco, Andrea; Bezares, Susana; Urriticoechea, Ander
Real-world features and outcomes of young advanced breast cancer (ABC) patients (pts) from RegistEM (GEICAM/2014-03) study
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Lopez-Tarruella, Sara; Guerrero, Angel; Alvarez, Isabel; Novoa, Silvia Antolin; Tibau, Ariadna; Cruz, Josefina; Rodriguez, Cesar A.; Martinez, Purificacion; Chacon, J. Ignacio; Hernandez, Maria; Margeli, Mireia; Adrover, Encarna; Falo, Catalina; Gonzalez, Iria; Rodriguez-Lescure, Alvaro; Marin, Maria; Gomez, Cesar; de la Haba-Rodriguez, Juan; Illaramendi, J. Jose; Andres, Raquel; Blasco, Andrea; Escudero, Ma Jose; Bezares, Susana; Rojo, Federico
SUMIT-ELA: Phase 1b/2 combination of cyclin-dependent kinase 7 inhibitor (CDK7i) samuraciclib and selective estrogen receptor degrader (SERD) elacestrant in advanced hormone receptor positive (HR plus ) breast cancer after CDK4/6i
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Patnaik, Amita; Novoa, Silvia Antolin; Bellet-Ezquerra, Meritxell; Bidard, Francois-Clement; Boni, Valentina; Brunet, Maxime; Campone, Mario; Garay, Carlos; Gomez-Bravo, Raquel; Howell, Sacha; Jeselsohn, Rinath; Lord, Simon; Mazzei, Paolo; De Miguel, Maria; Roesch, Erin; Stradella, Agostina; Vanacker, Helene; Vicier, Cecile; Wander, Seth; Clack, Glen; McIntosh, Stuart
Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
PRE
Lopez-Tarruella Cobo, S.; Stradella, A.; Tolosa Ortega, P.; Antolin-Novoa, S.; Santisteban Eslava, M.; Garcia-Corbacho, J.; Guerrero Zotano, A. L.; Ruiz Borrego, M.; Munoz Caffarel, M.; Losic, N.; Gyllenback, E. Jaensson; Skoog, P.; Johansen Blanco, H.; Soto-Castillo, J. J.; Alva Bianchi, M.; Reboredo Rendo, C.; Casas, M.; Caparroso, N.; Bezares Montes, S.; Ribas, I. Garcia
NEOADYUVANT TREATMENT IN THE COVID ERA
CANCER RESEARCH
IF16.6
2023-03-010
OA
de Castro, Beatriz Alonso; Rodriguez, Igor Gomez-Randulfe; Diaz, Sofia Silva; Reboredo, Cristina; Novoa, Silvia Antolin; Lopez, Eva Perez; Cordeiro, Patricia; Lesta, Rocio; Vazquez, Iria Parajo; Calvo, Lourdes
Real-world data of Advanced Breast Cancer (ABC) patients with HER2-positivity before the second-line therapy: data from the observational study GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Lopez-Tarruella, Sara; Guerrero-Zotano, Angel; Cruz, Josefina; Novoa, Silvia Antolin; Martinez, Purificacion; Hernandez, Maria; Rodriguez, Cesar A.; Chacon, J. Ignacio; Tibau, Ariadna; Falo, Catalina; Rodriguez-Lescure, Alvaro; Margeli, Mireia; Servitja, Sonia; Andres, Raquel; Galan-Gramaje, Maria; Adrover, Encarna; Miguel, Ana; Villanueva, Rafael; Varela, Silvia; Campo, Ruth; Escudero, Ma Jose; Bezares, Susana; Rojo, Federico; Alvarez, Isabel
Features and survival outcomes of HER2-low patients from a prospective registry of unresectable locally advanced or metastatic breast cancer: GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Alvarez, Isabel; Guerrero-Zotano, Angel; Tibau, Ariadna; Falo, Catalina; Hernandez, Maria; Miguel, Ana; Andres, Raquel; Rodriguez-Lescure, Alvaro; Corbellas, Miguel; Lopez-Tarruella, Sara; Martinez, Purificacion; Rodriguez, Cesar A.; Malon, Diego; Marin, Maria; Echarri, Ma Jose; Anton, Antonio; Cruz, Josefina; Moreno, Diana; Chacon, J. Ignacio; Campo, Ruth; Blasco, Andrea; Bezares, Susana; Rojo, Federico; Antolin, Silvia
Treatment strategies for advanced triple negative breast cancer patients as per routine clinical practice: analysis from the observational study GEICAM/2014-03 (RegistEM)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Novoa, Silvia Antolin; Rodriguez, Cesar A.; Cruz, Josefina; Lopez-Tarruella, Sara; Tibau, Ariadna; Adrover, Encarna; Miguel, Ana; Margeli, Mireia; Martinez, Purificacion; Hernandez, Maria; Anton, Antonio; Rodriguez-Lescure, Alvaro; Falo, Catalina; Alvarez, Isabel; Malon, Diego; Andres, Raquel; Alonso-Romero, Jose L.; Gomez, Cesar; Illaramendi, J. Jose; Campo, Ruth; Miralles, Juan Jose; Bezares, Susana; Rojo, Federico; Guerrero-Zotano, Angel
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

曲妥珠单抗deruxtecan与曲妥珠单抗emtansine在HER2-positive转移性乳腺癌患者中的比较: 来自DESTINY-Breast03的更新结果，一项随机，开放标签，3期试验

LANCET
IF88.5
2023-01-01298
OAAI
Hurvitz, Sara A.; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, Jose Manuel; Kim, Sung-Bae; Petry, Vanessa; Huang, Chiun-Sheng; Li, Wei; Frenel, Jean-Sebastien; Antolin, Silvia; Yeo, Winnie; Bianchini, Giampaolo; Loi, Sherene; Tsurutani, Junji; Egorov, Anton; Liu, Yali; Cathcart, Jillian; Ashfaque, Shahid; Cortes, Javier

研究方向

暂未获取到该数据
J
José Ignacio Chacón
H 指数:24论文数:175被引数:3,413
F
Federico Rojo
H 指数:71论文数:782被引数:2.3万
E
Eva Carrasco
H 指数:36论文数:206被引数:5,783
M
Miguel Martín
H 指数:107论文数:1,252被引数:4.6万
J
José Á. García-Sáenz
H 指数:51论文数:521被引数:1.4万
M
Montserrat Muñoz-Mateu
H 指数:50论文数:620被引数:9,886
Á
Ángel Guerrero‐Zotano
H 指数:25论文数:262被引数:4,072
L
Lourdes Calvo
H 指数:37论文数:241被引数:6,015
S
Susana Bezares
H 指数:11论文数:72被引数:972
R
Rosalía Caballero
H 指数:26论文数:241被引数:3,870